Elastomeric parts for parenterals and for devices for pharmaceutical use - Part 3: Determination of released-particle count - Amendment 1 (ISO 8871-3:2003/Amd 1:2018)

Elastomere Teile für Parenteralia und für Geräte zur pharmazeutischen Verwendung - Teil 3: Bestimmung von herausgelösten Partikeln - Änderung 1 (ISO 8871-3:2003/Amd 1:2018)

Éléments en élastomère pour administration parentérale et dispositifs à usage pharmaceutique - Partie 3: Détermination des particules libérées - Amendement 1 (ISO 8871-3:2003/Amd 1:2018)

Deli iz elastomera za parenteralne farmacevtske oblike - 3. del: Ugotavljanje deleža sproščenih delcev - Dopolnilo A1 (ISO 8871-3:2003/Amd 1:2018)

General Information

Status
Published
Public Enquiry End Date
04-Nov-2018
Publication Date
10-Apr-2019
Technical Committee
VAZ - Healthcare
Current Stage
6060 - National Implementation/Publication (Adopted Project)
Start Date
10-Apr-2019
Due Date
15-Jun-2019
Completion Date
11-Apr-2019

Relations

Effective Date
01-May-2019

Overview

SIST EN ISO 8871-3:2004/A1:2019 is a European amendment to the international standard ISO 8871-3:2003/Amd 1:2018. It focuses on elastomeric parts used in parenteral and pharmaceutical devices, specifically detailing the method for the determination of released-particle count from these components. This standard is essential for ensuring the safety and quality of elastomeric components such as stoppers, seals, and other parts that come into contact with injectable drugs.

Produced under the coordination of the European Committee for Standardization (CEN), this amendment harmonizes testing procedures across European member countries, ensuring compliance with regulatory requirements for medical and pharmaceutical device manufacturers.

Key Topics

  • Scope of Elastomeric Parts: Applies to elastomer components intended for parenteral use and various pharmaceutical device applications, highlighting their critical role in drug delivery safety.

  • Released-Particle Count Determination: Specifies the standardized test methods for quantifying particles that may detach from elastomeric parts during handling or use. This addresses contamination risks related to injectable medications.

  • Testing Methods Update: Amendment 1 introduces additional guidance, such as allowing the use of shaking machines with different horizontal circle parameters provided that comparability and equivalency can be demonstrated. This flexibility supports laboratory adaptability while maintaining test integrity.

  • Harmonization and Compliance: Ensures consistent application across countries within the CEN network, facilitating market access and regulatory approvals of parenteral medical devices in Europe.

Applications

  • Pharmaceutical Manufacturing: Manufacturers of injectable drugs rely on elastomeric parts that comply with SIST EN ISO 8871-3:2004/A1:2019 to minimize risks of particulate contamination, thus safeguarding patient health.

  • Medical Device Production: Essential for producers of infusion sets, syringes, vial stoppers, and other non-active medical devices where elastomeric components interface with pharmaceutical substances.

  • Quality Control Laboratories: Guidance on particle count testing supports rigorous quality assurance and control processes aimed at meeting stringent pharmaceutical industry standards.

  • Regulatory Submissions: Provides a harmonized testing standard recognized by European regulatory bodies, facilitating smoother certification and market approval for medical devices and pharmaceutical packaging.

Related Standards

  • ISO 8871 Series: This part (Part 3) is one segment of the broader ISO 8871 collection addressing elastomeric components for pharmaceutical use.

  • CEN/TC 205 Standards: SIST EN ISO 8871-3:2004/A1:2019 corresponds with the work of CEN Technical Committee 205 on non-active medical devices, linking it to relevant quality and safety guidelines.

  • ISO/TC 76: Developed under the ISO technical committee focusing on transfusion, infusion, injection, and blood processing equipment, ensuring broad international consensus.

  • Pharmaceutical Quality Standards: Complements other pharmaceutical device standards addressing sterility, biocompatibility, and material suitability.


Keywords: elastomeric parts, parenteral devices, pharmaceutical use, released-particle count, SIST EN ISO 8871-3:2004/A1:2019, pharmaceutical packaging, particulate contamination, medical device standards, CEN, ISO 8871 series, quality control, injection equipment standards, pharmaceutical device testing.

Amendment

SIST EN ISO 8871-3:2004/A1:2019

English language
7 pages
Preview
Preview
e-Library read for
1 day

Get Certified

Connect with accredited certification bodies for this standard

BSI Group

BSI (British Standards Institution) is the business standards company that helps organizations make excellence a habit.

UKAS United Kingdom Verified

TÜV SÜD

TÜV SÜD is a trusted partner of choice for safety, security and sustainability solutions.

DAKKS Germany Verified

Sponsored listings

Frequently Asked Questions

SIST EN ISO 8871-3:2004/A1:2019 is a amendment published by the Slovenian Institute for Standardization (SIST). Its full title is "Elastomeric parts for parenterals and for devices for pharmaceutical use - Part 3: Determination of released-particle count - Amendment 1 (ISO 8871-3:2003/Amd 1:2018)". This standard covers: Elastomeric parts for parenterals and for devices for pharmaceutical use - Part 3: Determination of released-particle count - Amendment 1 (ISO 8871-3:2003/Amd 1:2018)

Elastomeric parts for parenterals and for devices for pharmaceutical use - Part 3: Determination of released-particle count - Amendment 1 (ISO 8871-3:2003/Amd 1:2018)

SIST EN ISO 8871-3:2004/A1:2019 is classified under the following ICS (International Classification for Standards) categories: 11.040.20 - Transfusion, infusion and injection equipment. The ICS classification helps identify the subject area and facilitates finding related standards.

SIST EN ISO 8871-3:2004/A1:2019 has the following relationships with other standards: It is inter standard links to SIST EN ISO 8871-3:2004. Understanding these relationships helps ensure you are using the most current and applicable version of the standard.

SIST EN ISO 8871-3:2004/A1:2019 is available in PDF format for immediate download after purchase. The document can be added to your cart and obtained through the secure checkout process. Digital delivery ensures instant access to the complete standard document.

Standards Content (Sample)


SLOVENSKI STANDARD
01-maj-2019
'HOLL]HODVWRPHUD]DSDUHQWHUDOQHIDUPDFHYWVNHREOLNHGHO8JRWDYOMDQMHGHOHåD
VSURãþHQLKGHOFHY'RSROQLOR$ ,62$PG
Elastomeric parts for parenterals and for devices for pharmaceutical use - Part 3:
Determination of released-particle count - Amendment 1 (ISO 8871-3:2003/Amd 1:2018)
Elastomere Teile für Parenteralia und für Geräte zur pharmazeutischen Verwendung -
Teil 3: Bestimmung von herausgelösten Partikeln - Änderung 1 (ISO 8871-3:2003/Amd
1:2018)
Éléments en élastomère pour administration parentérale et dispositifs à usage
pharmaceutique - Partie 3: Détermination des particules libérées - Amendement 1 (ISO
8871-3:2003/Amd 1:2018)
Ta slovenski standard je istoveten z: EN ISO 8871-3:2004/A1:2019
ICS:
11.040.20 Transfuzijska, infuzijska in Transfusion, infusion and
injekcijska oprema injection equipment
2003-01.Slovenski inštitut za standardizacijo. Razmnoževanje celote ali delov tega standarda ni dovoljeno.

EN ISO 8871-3:2004/A1
EUROPEAN STANDARD
NORME EUROPÉENNE
March 2019
EUROPÄISCHE NORM
ICS 11.040.20
English Version
Elastomeric parts for parenterals and for devices for
pharmaceutical use - Part 3: Determination of released-
particle count - Amendment 1 (ISO 8871-3:2003/Amd
1:2018)
Éléments en élastomère pour administration Elastomere Teile für Parenteralia und für Geräte zur
parentérale et dispositifs à usage pharmaceutique - pharmazeutischen Verwendung - Teil 3: Bestimmung
Partie 3: Détermination des particules libérées - von herausgelösten Partikeln - Änderung 1 (ISO 8871-
Amendement 1 (ISO 8871-3:2003/Amd 1:2018) 3:2003/Amd 1:2018)
This amendment A1 modifies the European Standard EN ISO 8871-3:2004; it was approved by CEN on 29 November 2018.

CEN members are bound to comply with the CEN/CENELEC Internal Regulations which stipulate the conditions for inclusion of
this amendment into the relevant national standard without any alteration. Up-to-date lists and bibliographical references
concerning such national standards may be obtained on application to the CEN-CENELEC Management Centre or to any CEN
member.
This amendment exists in three official versions (English, French, German). A version in any other language made by translation
under the responsibility of a CEN member into its own language and notified to the CEN-CENELEC Management Centre has the
same status as the official versions.

CEN members are the national standards bodies of Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia,
Finland, Former Yugoslav Republic of Macedonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania,
Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland,
Turkey and United Kingdom.
EUROPEAN COMMITTEE FOR STANDARDIZATION
COMITÉ EUROPÉEN DE NORMALISATION

EUROPÄISCHES KOMITEE FÜR NORMUNG

CEN-CENELEC Management Centre: Rue de la Science 23, B-1040 Brussels
© 2019 CEN All rights of exploitation in any form and by any means reserved Ref. No. EN ISO 8871-3:2004/A1:2019 E
worldwide for CEN national Members.

Contents Page
European foreword . 3

European foreword
The text of ISO 8871-3:2003/Amd 1:2018 has been prepared by Technical Committee ISO/TC 76
"Transfusion, infusion and injection, and blood processing equipment for medical and pharmaceutical
use” of the International Organization for Standardization (ISO) and has been taken over as
secretariat of which is held by DIN.
This European Standard shall be given the status of a national standard, either by publication of an
identical text or by endorsement, at the latest by September 2019, and conflicting national standards
shall be withdrawn at the latest by September 2019.
Attention is drawn to the possibility that some of the elements of this document may be the subject of
patent rights. CEN shall not be held responsible for identifying any or all such patent rights.
According to the CEN-CENELEC Internal Regulations, the national standards organiza
...

Questions, Comments and Discussion

Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.

Loading comments...